Table 2.
Clinical, laboratory findings and echocardiographic data of all patients in both groups.
|
| |||
|---|---|---|---|
| GROUP I (N = 842) (CONTROLLED HTN) | GROUP II (N = 148)(RESISTANT HTN) | P. VALUE | |
|
| |||
| BMI, (kg/m2) | 26.72 ± 4.45 | 29.18 ± 3.38 | 0.001* |
|
| |||
| Heart rate, (bpm) | 79.74 ± 15.2 | 81.99 ± 18.0 | 0.107 |
|
| |||
| Systolic BP, mmHg | 129.4 ± 11.6 | 159.5 ± 17.3 | 0.001* |
|
| |||
| Diastolic BP, mmHg | 80.59 ± 8.34 | 95.20 ± 8.76 | 0.001* |
|
| |||
| Fasting plasma glucose (mg/dl) | 118.5 ± 17.2 | 117.1 ± 16.6 | 0.362 |
|
| |||
| 2-h post prandial plasma glucose (mg/dl) (mg/dl) (mmol/L) | 167.8 ± 31.1 | 168.6 ± 40.5 | 0.784 |
|
| |||
| HbA1c % | 6.354 ± 1.26 | 6.428 ± 1.28 | 0.513 |
|
| |||
| Hemoglobin, g/dl | 12.05 ± 1.06 | 12.07 ± 1.05 | 0.825 |
|
| |||
| TSH (mlU/L) | 4.31 ± 1.91 | 4.53 ± 2.85 | 0.233 |
|
| |||
| Total cholesterol (mg/dl) | 223.9 ± 38.8 | 224.0 ± 45.1 | 0.982 |
|
| |||
| Triglycerides (mg/dl) | 165.8 ± 32.3 | 163.6 ± 27.6 | 0.428 |
|
| |||
| LDL (mg/dl) | 137.4 ± 27.0 | 141.3 ± 30.1 | 0.111 |
|
| |||
| HDL (mg/dl) | 43.68 ± 7.34 | 44.33 ± 7.93 | 0.324 |
|
| |||
| Serum creatinine (mg/dl) | 1.13 ± 0.50 | 1.25 ± 0.60 | 0.012* |
|
| |||
| e-GFR (mL/min/1.73 m2) | 92.09 ± 17.2 | 89.09 ± 15.0 | 0.047* |
|
| |||
| Albuminuria (mg/g) | 29.01 ± 5.01 | 29.12 ± 4.04 | 0.791 |
|
| |||
| Serum potassium (mmol/L) | 4.49 ± 0.79 | 4.48 ± 0.79 | 0.945 |
|
| |||
| Uric acid (mg/dl) | 5.69 ± 1.07 | 5.58 ± 1.30 | 0.250 |
|
| |||
| Ankle brachial index | 1.04 ± 0.14 | 1.02 ± 0.13 | 0.140 |
|
| |||
| LVEDD (cm) | 5.75 ± 0.51 | 5.71 ± 0.57 | 0.326 |
|
| |||
| LVESD (cm) | 3.85 ± 0.43 | 3.78 ± 0.44 | 0.088 |
|
| |||
| LVEF, (%) | 62.76 ± 3.77 | 62.54 ± 4.48 | 0.524 |
|
| |||
| LVH, n (%) | 395 (46.9%) | 88 (59.5%) | 0.005* |
|
| |||
| E/A | 1.37 ± 0.42 | 1.39 ± 0.42 | 0.631 |
|
| |||
| E/E’ | 11.5 ± 1.36 | 11.8 ± 1.03 | 0.019* |
|
| |||
| LAVI (ml/m2) | 33.6 ± 1.70 | 34.1 ± 3.04 | 0.016* |
|
| |||
| LVMI (gr/m2) | 115.2 ± 27.1 | 122.7 ± 25.3 | 0.002* |
|
| |||
| Carotid IMT (mm) | 0.99 ± 0.11 | 0.98 ± 0.10 | 0.274 |
|
| |||
BMI: body mass index, BP: blood pressure, HbA1c: glycated hemoglobin, TSH: thyroid stimulating hormones, LDL: low density lipoprotein, HDL: high density lipoprotein, e-GFR: estimated glomerular filtration rate, LVEDD: left ventricle end-diastolic dimensions, LVESD: left ventricle end-systolic dimensions LVEF: left ventricle ejection fraction, LVH: left ventricular hypertrophy, E: peak early diastolic velocity, A: peak late diastolic velocity, E’: peak early diastolic myocardial velocity, LAVI: left atrium volume index, LVMI: left ventricular mass index, IMT: intima media thickness, *: Significant P value.